Technology | Market | Products
John Kilborn (46) studied life sciences prior to completing his graduate studies in Business Administration in Australia. Until April 2005 he was European Vice President and General Manager Germany, Switzerland and Austria with Bristol-Myers Squibb Pharmaceuticals. Prior to this he was Managing Director Australia/New Zealand with Bristol-Myers Squibb. Diabetes has been a key therapeutic focus for much of his career. John Kilborn holds the CEO position, will be responsible for business development, strategy and general management.
